Keyphrases
Pharmacotherapy
100%
Amyotrophic Lateral Sclerosis
100%
Disease Progression
33%
Clinical Trials
22%
Cellular Pathways
22%
Neurodegenerative Diseases
11%
Small Molecules
11%
Molecular Pathways
11%
Rapidly Progressive
11%
Survival Benefit
11%
Drug pipeline
11%
Canada
11%
Lower Motor Neuron
11%
Upper Motor Neuron
11%
Stem Cell Transplantation
11%
Prolonged Survival
11%
Disease-modifying Therapy
11%
Riluzole
11%
Neuroprotective Agents
11%
Glutamatergic
11%
Inflammatory Stress
11%
Edaravone
11%
Case Endings
11%
First Approval
11%
Taurursodiol
11%
Preclinical Development
11%
Trial Network
11%
Investigational Product
11%
Phenylbutyrate
11%
Oxidative Stress Mechanism
11%
Collaborative Trial
11%
Adaptive Clinical Trial Design
11%
Medicine and Dentistry
Drug Therapy
100%
Amyotrophic Lateral Sclerosis
100%
Disease Exacerbation
33%
Clinical Trial
22%
Neurodegenerative Disorder
11%
Oxidative Stress
11%
Biological Product
11%
Neuroprotective Agent
11%
Stem Cell Therapy
11%
Hope
11%
Riluzole
11%
Disease Modifying Therapy
11%
Clinical Trial Design
11%
Edaravone
11%
Sodium Phenylbutyrate
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Amyotrophic Lateral Sclerosis
100%
Disease Exacerbation
33%
Clinical Trial
22%
Diseases
22%
Drug Development
11%
Neuroprotective Agent
11%
Biological Product
11%
Riluzole
11%
Edaravone
11%
Clinical Trial Design
11%
Sodium Phenylbutyrate
11%